This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

The Ostrich Phenomenon!

M. Brian Fennerty, MD

Arch Intern Med. 1993;153(21):2411-2412.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN THIS issue of the ARCHIVES, Levine and collaborators¹ described the results of a trial using the histamine₂ blocker nizatidine as a prophylactic agent against nonsteroidal antiinflammatory drug (NSAID)—induced ulceration of the upper gastrointestinal tract. Four hundred ninetysix predominantly white female patients with osteoarthritis were enrolled in a multicenter, double-blind, placebocontrolled trial of nizatidine, 150 mg twice a day, vs placebo and followed up endoscopically on a monthly basis for 3 months. The end point of the study was development of an ulcer of either the stomach or the duodenum. Although neither ulcer occurrence nor symptoms were improved by therapy with nizatidine, the data indicated that, in a subgroup of patients with either a prior history of peptic ulcer disease or age greater than 65 years, ulceration occurred less frequently in those taking nizatidine. However, neither duodenal nor gastric ulcers, when evaluated independently, showed an effect by treatment . . . [Full Text PDF of this Article]

Author Affiliations
Department of Medicine/Section of Gastroenterology Arizona Health Sciences Center 1501 N Campbell Ave Tucson, AZ 85724

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?